{"disease":{"id":"hypogammaglobulinemia-acquired","name":"hypogammaglobulinemia acquired"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06976476","title":"Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false},{"nct_id":"NCT06989541","title":"Immunoglobulin for Hypogammaglobulinemia Due to Chimeric Antigen Receptor T Cell Therapy","phase":"","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"University of Alberta","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}